Yamaji Y, Natsumeda Y, Yamada Y, Irino S, Weber G
Laboratory for Experimental Oncology, Indiana University School of Medicine, Indianapolis 46202-5200.
Life Sci. 1990;46(6):435-42. doi: 10.1016/0024-3205(90)90087-8.
Tiazofurin and retinoic acid synergistically induced differentiation and inhibited colony formation in HL-60 human promyelocytic leukemia cells in cell culture. The synergism was the result of different mechanisms of action, since the effect of tiazofurin, unlike that of retinoic acid, was prevented by addition of guanosine. Since it has been shown that tiazofurin down-regulated the expression of c-Ki-ras oncogene, and retinoic acid that of the myc oncogene, the joint impact of these drugs is of clinical interest particularly in end-stage leukemia where the therapeutic usefulness of tiazofurin has recently been demonstrated.
噻唑呋林和视黄酸在细胞培养中协同诱导HL-60人早幼粒细胞白血病细胞分化并抑制集落形成。这种协同作用是不同作用机制的结果,因为与视黄酸不同,加入鸟苷可阻止噻唑呋林的作用。由于已表明噻唑呋林可下调c-Ki-ras癌基因的表达,视黄酸可下调myc癌基因的表达,因此这些药物的联合作用在临床上具有重要意义,尤其是在终末期白血病中,最近已证明噻唑呋林在该疾病中具有治疗作用。